Target intelligence / Profile preview

Eukaryotic translation initiation factor 5A K50R mutant (eIF5A K50R)

Target
eIF5A K50R
Molecular classification
Translation factor, Mutant protein
01

Overview

Eukaryotic translation initiation factor 5A (eIF5A) is a highly conserved and essential protein in eukaryotes, playing a critical role in mRNA translation, particularly during the elongation phase. The unique feature of eIF5A is its post-translational modification at lysine residue 50 (K50), where the polyamine spermidine is enzymatically added to form hypusine. The K50R mutant is a specific variant of eIF5A in which lysine at position 50 is replaced by arginine. This substitution prevents the formation of hypusine, resulting in an inactive or non-functional form of eIF5A with respect to its canonical roles. This mutant is primarily used as a research tool to study the effects of hypusination deficiency.

Other names
Non-hypusinable eIF5AeIF5A1 K50ReIF5A2 K50RK50R eIF5A
02

Mechanism of action

N/A

03

Biological functions

Impaired mRNA translationCell growth arrestApoptosis (in some contexts)
04

Disease associations

Cancer (research context)Neurodevelopmental disorders (research context)Viral infections (research context)Metabolic disorders (research context)

Beyond the preview

Go deeper on Eukaryotic translation initiation factor 5A K50R mutant (eIF5A K50R).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation initiation factor 5A K50R mutant (eIF5A K50R).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call